These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1120 related items for PubMed ID: 19858404

  • 1. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J.
    J Clin Oncol; 2009 Dec 10; 27(35):5944-51. PubMed ID: 19858404
    [Abstract] [Full Text] [Related]

  • 2. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B.
    J Clin Oncol; 2009 Jan 10; 27(2):186-92. PubMed ID: 19064967
    [Abstract] [Full Text] [Related]

  • 3. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F.
    Science; 2006 Sep 29; 313(5795):1960-4. PubMed ID: 17008531
    [Abstract] [Full Text] [Related]

  • 4. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.
    J Clin Gastroenterol; 2009 Oct 29; 43(9):831-7. PubMed ID: 19461527
    [Abstract] [Full Text] [Related]

  • 5. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT.
    Clin Cancer Res; 2008 Aug 15; 14(16):5220-7. PubMed ID: 18698040
    [Abstract] [Full Text] [Related]

  • 6. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
    Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F, Galon J.
    Cancer Res; 2011 Feb 15; 71(4):1263-71. PubMed ID: 21303976
    [Abstract] [Full Text] [Related]

  • 7. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
    Camus M, Tosolini M, Mlecnik B, Pagès F, Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval P, Trajanoski Z, Fridman WH, Galon J.
    Cancer Res; 2009 Mar 15; 69(6):2685-93. PubMed ID: 19258510
    [Abstract] [Full Text] [Related]

  • 8. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
    Krajewska M, Kim H, Kim C, Kang H, Welsh K, Matsuzawa S, Tsukamoto M, Thomas RG, Assa-Munt N, Piao Z, Suzuki K, Perucho M, Krajewski S, Reed JC.
    Clin Cancer Res; 2005 Aug 01; 11(15):5451-61. PubMed ID: 16061861
    [Abstract] [Full Text] [Related]

  • 9. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
    Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman WH, Pagès F, Galon J.
    J Clin Oncol; 2011 Feb 20; 29(6):610-8. PubMed ID: 21245428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 20; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A.
    Clin Cancer Res; 2006 Feb 15; 12(4):1144-51. PubMed ID: 16489067
    [Abstract] [Full Text] [Related]

  • 18. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
    Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S, Syrjänen K, Collan Y, Pyrhönen S.
    Cancer Invest; 2010 Jan 15; 28(1):38-43. PubMed ID: 20001295
    [Abstract] [Full Text] [Related]

  • 19. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, Kolch W.
    J Clin Oncol; 2006 Dec 20; 24(36):5672-9. PubMed ID: 17179102
    [Abstract] [Full Text] [Related]

  • 20. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
    Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2004 May 20; 150(5):852-9. PubMed ID: 15149496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.